Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis

Local Institution, Birmingham

Local Institution, Huntsville

Local Institution, Phoenix

Local Institution, Tucson

Local Institution, Los Angeles

Local Institution, San Diego

Local Institution, Miami

Local Institution, Chicago

Local Institution, Boston

Local Institution, Duluth

Local Institution, New Brunswick

Local Institution, New York

Local Institution, Chapel Hill

Local Institution, Cincinnati

Local Institution, Cleveland

Local Institution, Portland

Local Institution, Nashville

Local Institution, Dallas

Local Institution, Salt Lake City

Local Institution, Seattle

Local Instiution, Brussels

Local Institution, Diepenbeek

Local Institution, Ghent

Local Institution, Liège

Local Institution, Mons

Local Institution, Pellenberg

Local Institution, Edmonton

Local Institution, St. John's

Local Institution, Calgary

Local Institution, Ottawa

Local Institution, Toronto

Local Institution, Montreal

Local Institution, Sherbrook

Local Institution, Ste-Foy

Local Institution, Saskatoon

Local Institution, Lille

Local Institution, Lyon

Local Institution, Montpellier

Local Institution, Paris

Local Institution, Rennes

Local Institution, Strasbourg

Local Institution, Toulouse

Local Institution, Berlin

Local Institution, Düsseldorf

Local Institution, Erlangen

Local Institution, Fankfurt

Local Institution, Hanover

Local Institution, Leipzig

Local Institution, München

Local Institution, Münster

Local Institution, Ratingen

Local Institution, Cork

Local Institution, Dublin

Local Institution, Amsterdam

Local Institution, Leiden

Local Institution, Nijmegen

Local Institution, Bern

Local Institution, Birmingham

Local Institution, Cambridge

Local Institution, Leeds